Clinical Approach to Lower Gastrointestinal Bleeding
Comprehensive Practical Framework1. Symptom Overview
Understanding the clinical significance and classification of Lower Gastrointestinal Bleeding
Lower gastrointestinal bleeding accounts for approximately 20-25% of all gastrointestinal hemorrhage cases and results in over 300,000 hospitalizations annually in the United States. While historically considered less severe than upper gastrointestinal bleeding, lower gastrointestinal bleeding carries a mortality rate of 2-4% and increases significantly to 10-20% in hospitalized patients who develop bleeding during admission. The incidence rises dramatically with age, being over 200 times more common in individuals over 80 years compared to those in their third decade of life.
Definition
Lower gastrointestinal bleeding refers to blood loss originating from the gastrointestinal tract distal to the ligament of Treitz. This encompasses bleeding from the jejunum, ileum, colon, rectum, and anal canal. Clinically, it most commonly presents as hematochezia (passage of bright red or maroon blood per rectum), though it may occasionally present as melena when bleeding is slow or originates from the small bowel.
Classification by Severity
| Category | Definition | Clinical Features | Management Implications |
|---|---|---|---|
| Mild (Occult) | Positive fecal occult blood test without visible bleeding | Often asymptomatic; may have iron deficiency anemia | Outpatient colonoscopy evaluation |
| Moderate | Visible bleeding with stable hemodynamics | Intermittent hematochezia; hemoglobin drop less than 3 g/dL | Urgent inpatient evaluation; colonoscopy within 24 hours |
| Severe (Massive) | Hemodynamic instability or need for transfusion | Continuous bleeding; heart rate greater than 100; systolic blood pressure less than 90 mmHg; transfusion requirement greater than 2 units | Intensive care unit admission; emergent intervention |
Classification by Acuity
| Category | Duration | Common Causes | Clinical Significance |
|---|---|---|---|
| Acute | Less than 3 days onset with ongoing or recent bleeding | Diverticular bleeding, angiodysplasia, post-polypectomy bleeding, ischemic colitis | Requires urgent evaluation; higher risk of hemodynamic compromise |
| Chronic | Slow, intermittent, or recurrent bleeding over weeks to months | Hemorrhoids, colorectal neoplasia, inflammatory bowel disease, radiation proctitis | Allows elective workup; focus on underlying etiology and malignancy exclusion |
| Obscure | Recurrent bleeding with negative upper and lower endoscopy | Small bowel angiodysplasia, small bowel tumors, Meckel diverticulum, Dieulafoy lesion | Requires specialized evaluation including capsule endoscopy or enteroscopy |
Classification by Clinical Presentation
Hematochezia
Passage of bright red or maroon blood per rectum. This is the most common presentation of lower gastrointestinal bleeding and typically indicates a colonic or anorectal source. However, approximately 10-15% of patients with severe hematochezia have an upper gastrointestinal source with rapid transit.
Melena
Black, tarry, foul-smelling stools resulting from degradation of blood by intestinal bacteria. While classically associated with upper gastrointestinal bleeding, melena can occur with right-sided colonic bleeding or small bowel hemorrhage when transit time is prolonged.
Classification by Anatomical Source
| Location | Frequency | Common Etiologies | Typical Presentation |
|---|---|---|---|
| Anorectal | Approximately 10-15% | Hemorrhoids, anal fissure, rectal varices, solitary rectal ulcer | Bright red blood on tissue or toilet bowl; often painless or with defecation pain |
| Colonic | Approximately 70-80% | Diverticulosis, angiodysplasia, colorectal cancer, polyps, colitis | Variable from bright red to maroon blood mixed with stool |
| Small Bowel | Approximately 5-10% | Angiodysplasia, tumors, Crohn disease, Meckel diverticulum, nonsteroidal anti-inflammatory drug enteropathy | Often obscure; may present as iron deficiency anemia or melena |
Key Concept: The “Big Five” Causes of Acute Lower Gastrointestinal Bleeding
In adults, five conditions account for the majority of acute lower gastrointestinal bleeding requiring hospitalization:
- Diverticulosis — most common cause (30-40%); typically painless, self-limited bleeding
- Angiodysplasia — vascular ectasias (10-20%); more common in elderly and those with renal failure
- Colorectal neoplasia — polyps and cancer (10-15%); often chronic, occult bleeding
- Colitis — ischemic, infectious, or inflammatory (10-20%); associated with abdominal pain and diarrhea
- Anorectal disease — hemorrhoids and fissures (5-10%); bright red blood, often with defecation
Age-Related Patterns in Etiology
| Age Group | Most Common Causes | Key Considerations |
|---|---|---|
| Young Adults (18-40 years) | Hemorrhoids, inflammatory bowel disease, infectious colitis, Meckel diverticulum | Lower threshold for colonoscopy if family history of colorectal cancer or alarming features |
| Middle-Aged (40-60 years) | Diverticulosis, colorectal neoplasia, hemorrhoids, inflammatory bowel disease | Mandatory malignancy exclusion; colonoscopy indicated for all new presentations |
| Elderly (greater than 60 years) | Diverticulosis, angiodysplasia, colorectal cancer, ischemic colitis | Higher risk of hemodynamic compromise; consider anticoagulant and antiplatelet use |
Clinical Impact and Natural History
Lower gastrointestinal bleeding is self-limited in 80-85% of cases, stopping spontaneously without intervention. However, approximately 15-20% of patients will have recurrent bleeding, and the rebleeding rate for specific conditions varies significantly: diverticular bleeding has a 25-40% recurrence rate, while angiodysplasia may rebleed in up to 50% of cases. The probability of identifying a source increases with the severity of bleeding and the timing of colonoscopy.
2. Pathophysiology and Mechanisms
Understanding the underlying mechanisms of Lower Gastrointestinal Bleeding
Understanding the pathophysiology of lower gastrointestinal bleeding is essential for rational diagnosis and management. Bleeding occurs when there is disruption of the mucosal barrier or vascular integrity within the gastrointestinal tract. The mechanism varies considerably depending on the underlying etiology, and recognizing these mechanisms helps predict bleeding behavior, guide diagnostic testing, and select appropriate interventions.
Fundamental Mechanisms of Gastrointestinal Bleeding
| Mechanism Category | Pathophysiology | Associated Conditions | Bleeding Characteristics |
|---|---|---|---|
| Arterial Rupture | Erosion into or rupture of arterial vessels | Diverticular bleeding, Dieulafoy lesion, post-polypectomy bleeding | Sudden onset, high volume, intermittent, often self-limited |
| Vascular Malformation | Abnormal, fragile vessels prone to spontaneous bleeding | Angiodysplasia, radiation telangiectasia, hereditary hemorrhagic telangiectasia | Chronic, recurrent, low to moderate volume |
| Mucosal Inflammation | Inflammatory damage to mucosa with vessel exposure | Inflammatory bowel disease, infectious colitis, ischemic colitis | Associated with diarrhea and abdominal pain; bloody mucus common |
| Mucosal Ischemia | Hypoperfusion leading to mucosal necrosis and hemorrhage | Ischemic colitis, strangulated hernia, mesenteric ischemia | Acute onset with abdominal pain; watershed areas affected |
| Neoplastic Invasion | Tumor erosion into blood vessels or friable tumor surface | Colorectal cancer, polyps, gastrointestinal stromal tumors | Chronic, occult, or intermittent overt bleeding |
| Venous Congestion | Elevated venous pressure causing vessel dilation and rupture | Hemorrhoids, rectal varices in portal hypertension | Associated with straining; bright red, often post-defecation |
| Mechanical Trauma | Physical disruption of mucosa and underlying vessels | Anal fissure, stercoral ulcer, foreign body, post-procedural | Related to specific precipitant; painful if anal involvement |
Pathophysiology by Specific Conditions
Diverticular Bleeding
Mechanism of Diverticular Hemorrhage
Colonic diverticula are acquired herniations of mucosa and submucosa through the muscular layer at points where the vasa recta (penetrating arteries) enter the bowel wall. Over time, the vasa recta become draped over the dome of the diverticulum and are separated from the bowel lumen only by mucosa. Chronic trauma from fecal material causes asymmetric intimal thickening and thinning of the media, predisposing to arterial rupture into the diverticular sac. Importantly, diverticular bleeding occurs in the absence of diverticulitis—the mechanism is vascular, not inflammatory.
Angiodysplasia
Mechanism: Angiodysplasias are degenerative vascular lesions resulting from chronic, intermittent obstruction of submucosal veins where they penetrate the muscular layer. This obstruction, occurring during muscular contraction, leads to progressive dilation of the submucosal veins, then venules, and eventually the capillary ring, forming arteriovenous communications. The cecum is most commonly affected due to higher wall tension (Law of Laplace).
Clinical relevance: The thin-walled, dilated vessels are prone to spontaneous bleeding. Association with aortic stenosis (Heyde syndrome) involves acquired von Willebrand factor deficiency from shear stress across the stenotic valve.
Ischemic Colitis
Mechanism: Ischemic colitis results from transient hypoperfusion of the colon, most commonly in “watershed” areas (splenic flexure, rectosigmoid junction) where collateral circulation is limited. Reduced blood flow causes mucosal ischemia, which is most sensitive to hypoxia. Reperfusion injury compounds the damage through reactive oxygen species generation. The mucosa becomes edematous, hemorrhagic, and may ulcerate.
Clinical relevance: Often occurs in elderly patients with cardiovascular disease, after hypotensive episodes, or following aortic surgery. Typically presents with sudden abdominal pain followed by bloody diarrhea within 24 hours.
Colorectal Neoplasia
| Lesion Type | Bleeding Mechanism | Typical Presentation |
|---|---|---|
| Adenomatous Polyps | Surface erosion and friable neovascularization; larger polyps (greater than 1 cm) bleed more frequently | Intermittent occult bleeding; iron deficiency anemia |
| Colorectal Adenocarcinoma | Tumor necrosis, ulceration, and erosion into vessels; right-sided tumors often present with anemia, left-sided with hematochezia | Chronic occult blood loss; change in bowel habits; late-stage may cause overt bleeding |
| Post-Polypectomy Bleeding | Inadequate vessel coagulation during polypectomy or sloughing of eschar; immediate (within 24 hours) or delayed (up to 2 weeks) | Sudden hematochezia days after colonoscopy; often arterial and significant |
Inflammatory Bowel Disease
Ulcerative Colitis
- Pattern: Continuous mucosal inflammation starting at rectum
- Mechanism: Immune-mediated mucosal damage with crypt abscesses, ulceration, and capillary friability
- Bleeding: Bloody diarrhea with mucus is hallmark; severity correlates with disease extent
Crohn Disease
- Pattern: Transmural, skip lesions; can affect any segment
- Mechanism: Deep ulceration can erode into larger vessels; fistula formation may involve vessels
- Bleeding: Less common than ulcerative colitis; massive bleeding rare but can occur from deep ulcers
Relevant Vascular Anatomy
| Arterial Supply | Territory | Clinical Significance |
|---|---|---|
| Superior Mesenteric Artery | Small bowel, cecum, ascending colon, proximal transverse colon | Right-sided colonic lesions; Supplies ileocolic, right colic, and middle colic arteries |
| Inferior Mesenteric Artery | Distal transverse colon, descending colon, sigmoid colon, upper rectum | Left-sided colonic lesions; Splenic flexure is watershed zone |
| Internal Iliac Arteries | Middle and lower rectum, anal canal | Hemorrhoidal plexus; Dual blood supply makes rectal ischemia rare |
| Marginal Artery of Drummond | Collateral arcade along mesenteric border | Provides collateral flow; Disruption during surgery can cause ischemia |
Anorectal Vascular Mechanisms
Internal Hemorrhoids
Location: Above dentate line; superior hemorrhoidal plexus
Mechanism: Straining increases intra-abdominal pressure, engorging the hemorrhoidal cushions. Repeated trauma from defecation causes erosion of overlying mucosa with arterial bleeding from submucosal arterioles.
Bleeding character: Bright red, painless (above dentate line), drips into toilet or on tissue
External Hemorrhoids
Location: Below dentate line; inferior hemorrhoidal plexus
Mechanism: Thrombosis of external hemorrhoidal veins causes acute, painful swelling. Bleeding occurs if the overlying skin erodes or if thrombosis resolves with ulceration.
Bleeding character: Associated with significant perianal pain; bleeding often minor unless thrombosed hemorrhoid erodes
Anal Fissure
Location: Linear tear in anoderm, usually posterior midline
Mechanism: Passage of hard stool causes mechanical tear. Internal anal sphincter spasm reduces blood flow, impairing healing. Chronic fissures develop fibrosis and sentinel pile.
Bleeding character: Bright red blood on tissue; severe pain with and after defecation
Factors That Affect Bleeding Severity
| Factor | Mechanism of Effect | Clinical Implication |
|---|---|---|
| Anticoagulant Therapy | Inhibits coagulation cascade; prevents clot formation and stabilization | Does not cause bleeding but unmasks lesions and prolongs bleeding; reversal may be needed |
| Antiplatelet Agents | Inhibits platelet aggregation; impairs primary hemostasis | Aspirin and clopidogrel increase risk of diverticular and angiodysplastic bleeding |
| Nonsteroidal Anti-Inflammatory Drugs | COX inhibition reduces prostaglandin-mediated mucosal protection; direct mucosal injury | Can cause ulceration throughout gastrointestinal tract, including small bowel and colon |
| Portal Hypertension | Increased portal pressure dilates portosystemic collaterals including rectal varices | Rectal varices may cause massive bleeding; also associated with coagulopathy |
| Chronic Kidney Disease | Uremic platelet dysfunction; increased angiodysplasia formation; altered drug clearance | Higher prevalence of angiodysplasia and bleeding complications |
Often Overlooked Mechanism: Small Bowel Bleeding
When upper endoscopy and colonoscopy are negative, small bowel sources account for 5-10% of gastrointestinal bleeding. Angiodysplasia of the small bowel is the most common cause, particularly in elderly patients and those with chronic kidney disease. Nonsteroidal anti-inflammatory drug enteropathy causes characteristic diaphragm-like strictures and ulceration in the small bowel that are not visible on standard endoscopy. Meckel diverticulum, containing ectopic gastric mucosa, should be considered in patients under 40 with obscure gastrointestinal bleeding. These lesions require specialized diagnostic approaches including capsule endoscopy, deep enteroscopy, or nuclear medicine scanning.
How Mechanisms Inform Treatment
| Condition | Primary Mechanism | Treatment Implication |
|---|---|---|
| Diverticular Bleeding | Arterial rupture over diverticular dome | Endoscopic hemostasis (clips, injection); angiographic embolization if endoscopy fails |
| Angiodysplasia | Fragile, thin-walled ectatic vessels | Argon plasma coagulation; may recur and require repeated treatment |
| Ischemic Colitis | Mucosal hypoperfusion and reperfusion injury | Supportive care; optimize cardiac output; avoid vasoconstrictors; surgery if transmural necrosis |
| Inflammatory Bowel Disease | Immune-mediated mucosal ulceration | Control inflammation with immunosuppressive therapy; transfusion support |
| Post-Polypectomy Bleeding | Exposed vessel at polypectomy site | Endoscopic clip placement; injection therapy |
| Hemorrhoids | Venous engorgement with mucosal erosion | Conservative management; rubber band ligation; hemorrhoidectomy if refractory |
3. History Taking
A comprehensive approach to eliciting the lower gastrointestinal bleeding history
Red Flags — Require Urgent Evaluation
- Hemodynamic instability — Tachycardia, hypotension, syncope suggest massive hemorrhage
- Ongoing large-volume bleeding — Continuous passage of blood or clots indicates active arterial bleeding
- Anticoagulant use with significant bleeding — May require reversal and indicates higher risk
- Age greater than 60 with new bleeding — Higher risk of malignancy and serious pathology
- Associated severe abdominal pain — Suggests ischemic colitis, mesenteric ischemia, or perforation
- Unintentional weight loss — Raises concern for underlying malignancy
- Family history of colorectal cancer — Indicates need for thorough neoplasia evaluation
- Recent aortic surgery or cardiac catheterization — Risk of atheroembolic or ischemic colitis
Systematic History: The “BLEED” Approach
Use the mnemonic “BLEED” to ensure comprehensive history taking for lower gastrointestinal bleeding:
- B — Blood characteristics: Color, volume, mixed with stool or separate, clots present?
- L — Location clues: On tissue only, in toilet bowl, coating stool, or mixed throughout?
- E — Episodes and duration: First episode or recurrent? Acute onset or chronic? How many episodes?
- E — Extra symptoms: Abdominal pain, weight loss, change in bowel habits, fever, tenesmus?
- D — Drugs and diseases: Anticoagulants, NSAIDs, prior gastrointestinal disease, liver disease, recent procedures?
Characterizing the Bleeding
| Characteristic | Description | Suggests | Key Question to Ask |
|---|---|---|---|
| Bright red blood | Fresh, arterial appearance | Anorectal source or rapid colonic transit | “Is the blood bright red like fresh blood?” |
| Dark red or maroon blood | Partially degraded blood | Right colon or small bowel source | “Is the blood darker, like a burgundy or maroon color?” |
| Blood on toilet paper only | Small volume, surface bleeding | Hemorrhoids, anal fissure | “Do you only notice blood when you wipe?” |
| Blood coating stool | Blood applied to formed stool | Distal colonic or rectal source | “Is the blood on the outside of the stool?” |
| Blood mixed with stool | Incorporated throughout | Proximal colonic source | “Is the blood mixed in with the stool?” |
| Blood with mucus | Bloody mucoid discharge | Inflammatory bowel disease, infectious colitis, rectal tumor | “Do you notice any mucus or slime with the blood?” |
| Clots passed | Formed blood clots | Significant volume bleeding; often diverticular | “Have you passed any blood clots?” |
| Melena (black, tarry stool) | Degraded blood, foul odor | Upper gastrointestinal source or slow right colon bleeding | “Are your stools black and tarry, with a distinctive smell?” |
Targeted Questions by Suspected Cause
| Suspected Cause | Key Features | Ask This Question |
|---|---|---|
| Diverticular bleeding | Sudden, painless, large-volume bleeding; older patient | “Did the bleeding come on suddenly without warning? Was there any pain with it?” |
| Hemorrhoids | Bright red blood on wiping; associated with constipation or straining | “Do you have to strain during bowel movements? Do you have any anal itching or discomfort?” |
| Anal fissure | Severe pain with defecation; bright red blood on tissue | “Do you have sharp pain during and after bowel movements? Does it feel like passing glass?” |
| Colorectal cancer | Change in bowel habits, weight loss, older age, family history | “Have you noticed any change in your bowel habits? Any unintentional weight loss? Any family history of colon cancer?” |
| Inflammatory bowel disease | Bloody diarrhea, abdominal cramping, young to middle-aged patient | “Do you have frequent loose stools with blood and mucus? Any cramping before bowel movements?” |
| Ischemic colitis | Sudden abdominal pain followed by bloody diarrhea within 24 hours | “Did you have sudden abdominal pain that was followed by bloody diarrhea? Do you have heart disease or recent low blood pressure?” |
| Infectious colitis | Fever, diarrhea, recent travel, sick contacts, antibiotic use | “Do you have fever? Any recent travel, camping, or new food exposures? Have you taken antibiotics recently?” |
| Angiodysplasia | Recurrent bleeding episodes, older age, renal disease, aortic stenosis | “Have you had multiple episodes of bleeding over time? Do you have kidney disease or a heart murmur?” |
| Post-polypectomy bleeding | Recent colonoscopy with polypectomy, delayed bleeding 1-14 days after | “Have you had a colonoscopy with polyp removal in the past two weeks?” |
| Radiation proctitis | History of pelvic radiation, chronic rectal bleeding, tenesmus | “Have you ever had radiation treatment to your pelvis for cancer?” |
Associated Symptoms and Their Significance
| Associated Symptom | Significance | Consider These Diagnoses |
|---|---|---|
| Painless bleeding | Suggests vascular source without inflammation | Diverticulosis, angiodysplasia, hemorrhoids, colorectal cancer |
| Abdominal pain with bleeding | Indicates inflammatory, ischemic, or obstructive process | Ischemic colitis, inflammatory bowel disease, infectious colitis, complicated diverticular disease |
| Pain with defecation | Anorectal pathology | Anal fissure, thrombosed hemorrhoid, proctitis |
| Diarrhea | Inflammatory or infectious process | Inflammatory bowel disease, infectious colitis, ischemic colitis |
| Constipation | May cause or exacerbate anorectal bleeding | Hemorrhoids, anal fissure, stercoral ulcer |
| Tenesmus | Rectal irritation or mass effect | Proctitis, rectal cancer, inflammatory bowel disease |
| Weight loss | Concerning for malignancy or chronic inflammatory disease | Colorectal cancer, inflammatory bowel disease |
| Fever | Infectious or severe inflammatory process | Infectious colitis, severe inflammatory bowel disease, diverticulitis |
Medication and Social History
Medications That Increase Bleeding Risk
- Anticoagulants — Warfarin, direct oral anticoagulants (rivaroxaban, apixaban, dabigatran, edoxaban); do not cause bleeding but unmask lesions and prolong hemorrhage
- Antiplatelet agents — Aspirin, clopidogrel, prasugrel, ticagrelor; associated with increased diverticular and angiodysplastic bleeding
- Nonsteroidal anti-inflammatory drugs — Can cause ulceration throughout the gastrointestinal tract; increase bleeding from pre-existing lesions
- Corticosteroids — Impair mucosal healing; may mask symptoms of perforation
- Selective serotonin reuptake inhibitors — Inhibit platelet serotonin uptake; increase bleeding risk especially with concurrent NSAID or antiplatelet use
Critical History Elements
- Prior colonoscopy findings: Previous polyps, diverticula, angiodysplasia, or inflammatory bowel disease
- Prior gastrointestinal bleeding episodes: Pattern suggests recurrent source (angiodysplasia, diverticula)
- Recent procedures: Colonoscopy with polypectomy within 2 weeks; aortic surgery; cardiac catheterization
- Liver disease: Coagulopathy, portal hypertension with rectal varices
- Chronic kidney disease: Associated with angiodysplasia and platelet dysfunction
- Aortic stenosis: Associated with acquired von Willebrand syndrome and angiodysplasia (Heyde syndrome)
- Radiation history: Pelvic radiation for prostate, cervical, or rectal cancer can cause radiation proctitis
Social and Family History
| Factor | Relevance | What to Ask |
|---|---|---|
| Family history of colorectal cancer | Increased risk of neoplasia; may indicate hereditary syndrome | “Has anyone in your family had colon cancer or polyps? At what age?” |
| Family history of inflammatory bowel disease | Genetic predisposition | “Does anyone in your family have Crohn’s disease or ulcerative colitis?” |
| Alcohol use | Liver disease with coagulopathy and portal hypertension | “How much alcohol do you drink? Have you ever been told you have liver problems?” |
| Smoking history | Associated with Crohn disease; cardiovascular disease predisposes to ischemia | “Do you smoke or have you ever smoked?” |
| Sexual practices | Receptive anal intercourse associated with proctitis, trauma, sexually transmitted infections | “Are you sexually active? Do you engage in receptive anal intercourse?” |
| Travel history | Infectious colitis from endemic pathogens | “Have you traveled recently, especially to developing countries?” |
| Diet and fiber intake | Low fiber associated with diverticular disease and constipation | “How would you describe your diet? Do you eat much fiber, fruits, and vegetables?” |
Quantifying Blood Loss from History
Patients often overestimate or underestimate blood loss. Use these reference points to help quantify:
- Blood on tissue only: Minimal blood loss (less than 5 mL per episode)
- Blood turning toilet water pink: Approximately 5-10 mL
- Blood turning toilet water red: Approximately 30-50 mL
- Clots in toilet bowl: Typically greater than 50 mL per episode; significant bleeding
- Lightheadedness or syncope: Suggests greater than 15% blood volume loss (more than 750 mL)
Also ask about symptoms of anemia: fatigue, exertional dyspnea, lightheadedness, which suggest chronic blood loss.
4. Physical Examination
A systematic head-to-toe approach for lower gastrointestinal bleeding
Systematic Framework: Use the “Assess Stability → General → Abdominal → Anorectal” approach for complete examination of patients presenting with lower gastrointestinal bleeding. The initial priority is always hemodynamic assessment.
Immediate Hemodynamic Assessment
Signs of Hemodynamic Compromise
Assess these immediately upon patient contact:
- Altered mental status — Confusion, agitation, or lethargy indicates cerebral hypoperfusion
- Tachycardia — Heart rate greater than 100 beats per minute suggests greater than 15% blood volume loss
- Hypotension — Systolic blood pressure less than 90 mmHg indicates greater than 30% blood volume loss
- Orthostatic changes — Drop in systolic blood pressure greater than 20 mmHg or rise in heart rate greater than 20 beats per minute upon standing
- Cool, clammy extremities — Peripheral vasoconstriction from shock
- Delayed capillary refill — Greater than 3 seconds indicates poor perfusion
Vital Signs
| Vital Sign | What to Look For | Clinical Significance |
|---|---|---|
| Heart Rate | Tachycardia (greater than 100 beats per minute); note if on beta-blockers which blunt response | Early sign of volume depletion; may be masked by medications |
| Blood Pressure | Hypotension (systolic less than 90 mmHg); narrowed pulse pressure | Suggests greater than 30% blood volume loss; late sign |
| Orthostatic Vital Signs | Check lying and standing; positive if systolic drops greater than 20 mmHg or heart rate rises greater than 20 | Indicates 15-20% blood volume loss; perform if patient stable enough |
| Respiratory Rate | Tachypnea (greater than 20 breaths per minute) | Compensatory response to anemia; may indicate acidosis in severe shock |
| Temperature | Fever (greater than 38°C) | Suggests infectious colitis, inflammatory bowel disease flare, or diverticulitis |
| Oxygen Saturation | May be normal despite significant anemia; hypoxia in severe cases | Pulse oximetry measures saturation, not oxygen-carrying capacity |
General Inspection
- Appearance: Level of distress, position of comfort, ability to converse
- Pallor: Check conjunctivae, oral mucosa, palmar creases — suggests anemia
- Jaundice: Scleral icterus suggests liver disease with possible coagulopathy and portal hypertension
- Stigmata of chronic liver disease: Spider angiomata, palmar erythema, gynecomastia, caput medusae — suggests portal hypertension
- Signs of malignancy: Cachexia, lymphadenopathy (especially left supraclavicular — Virchow node)
- Skin findings: Purpura or petechiae suggest coagulopathy; dermatitis herpetiformis or pyoderma gangrenosum suggest inflammatory bowel disease
Abdominal Examination
Inspection
- Distension — may suggest obstruction or ascites
- Surgical scars — previous abdominal surgery, ostomy sites
- Caput medusae — portal hypertension
- Visible masses or asymmetry
Auscultation
- Hyperactive bowel sounds: Blood is cathartic; brisk bleeding causes increased motility
- High-pitched or absent bowel sounds: May suggest ischemia or obstruction
- Bruits: May indicate vascular disease predisposing to ischemia
Palpation
- Tenderness: Localized tenderness suggests inflammatory process (colitis, diverticulitis); diffuse tenderness suggests peritonitis
- Guarding and rigidity: Suggests peritoneal irritation — may indicate perforation or transmural ischemia
- Masses: May represent tumor, inflammatory phlegmon, or fecal impaction
- Hepatosplenomegaly: Liver disease, portal hypertension
- Ascites: Shifting dullness, fluid wave — suggests portal hypertension or malignancy
Percussion
- Tympany — normal or increased with bowel distension
- Dullness — may suggest mass, ascites, or organomegaly
- Shifting dullness — ascites
Anorectal Examination
Essential Component
The digital rectal examination is mandatory in all patients with lower gastrointestinal bleeding. It can identify anorectal pathology, assess stool color, and detect rectal masses. Never omit this examination.
External Inspection
- External hemorrhoids: Visible perianal swelling; may be thrombosed (blue, tense)
- Anal fissure: Usually posterior midline; may see sentinel pile (skin tag)
- Fistula openings: Associated with Crohn disease
- Perianal skin changes: Erythema, excoriation, ulceration, condylomata
- Prolapsing tissue: Prolapsed internal hemorrhoids, rectal prolapse
Digital Rectal Examination
| Finding | Description | Clinical Significance |
|---|---|---|
| Sphincter tone | Assess resting and squeeze tone | Reduced tone may indicate neurological disease; increased tone common with fissure |
| Rectal masses | Palpable mass within reach of examining finger | May represent rectal cancer (hard, fixed), polyp, or fecal impaction |
| Tenderness | Pain on palpation | Anal fissure (severe), proctitis, abscess |
| Blood on glove | Fresh red blood, dark blood, or melena | Confirms bleeding; color helps localize source |
| Stool color | Bright red, maroon, melenic, or brown | Helps differentiate upper from lower gastrointestinal source |
| Prostate (in males) | Size, nodules, tenderness | Enlarged prostate rarely causes hematochezia but important to assess |
Cardiovascular Examination
| Finding | What to Look For | Significance |
|---|---|---|
| Murmurs | Systolic ejection murmur at right upper sternal border | Aortic stenosis associated with angiodysplasia (Heyde syndrome) |
| Irregular rhythm | Irregularly irregular pulse | Atrial fibrillation — patient likely on anticoagulation |
| Elevated jugular venous pressure | Distended neck veins | Heart failure — may affect fluid resuscitation strategy |
| Peripheral edema | Bilateral lower extremity swelling | Heart failure or liver disease; affects volume assessment |
| Arterial pulses | Diminished or absent peripheral pulses | Peripheral vascular disease — suggests possible mesenteric vascular disease |
Extremities Examination
Clubbing
Finding: Loss of nail bed angle, increased nail curvature
Significance: Associated with inflammatory bowel disease, colorectal malignancy, cirrhosis
Koilonychia
Finding: Spoon-shaped nails
Significance: Iron deficiency anemia from chronic gastrointestinal blood loss
Peripheral Edema
Finding: Pitting edema of lower extremities
Significance: May indicate hypoalbuminemia from chronic disease, heart failure, or liver disease
Extra-intestinal Signs of Inflammatory Bowel Disease
| System | Finding | Description |
|---|---|---|
| Eyes | Episcleritis, uveitis | Red eye, photophobia, pain — may require ophthalmology evaluation |
| Skin | Erythema nodosum | Tender, red nodules on shins — correlates with disease activity |
| Skin | Pyoderma gangrenosum | Painful ulcers with violaceous borders — often on legs |
| Joints | Peripheral arthritis | Asymmetric, large joint involvement — correlates with bowel activity |
| Mouth | Aphthous ulcers | Painful oral ulcers — more common in Crohn disease |
Expected Physical Findings by Etiology
| Condition | General Appearance | Abdominal Findings | Anorectal Findings |
|---|---|---|---|
| Diverticular bleeding | May be hemodynamically unstable if severe | Usually non-tender; may have mild left lower quadrant tenderness | Bright red or maroon blood; no masses |
| Angiodysplasia | May have pallor from chronic anemia; aortic stenosis murmur | Usually benign | Blood on examination; no masses |
| Colorectal cancer | May have cachexia, pallor, lymphadenopathy | May have palpable mass; hepatomegaly if metastatic | May have palpable rectal mass; blood mixed with stool |
| Ischemic colitis | Often elderly with cardiovascular disease | Left-sided abdominal tenderness; may have peritoneal signs if severe | Bloody stool; rectal examination benign |
| Inflammatory bowel disease | May have extra-intestinal manifestations; weight loss | Tenderness along colon; may have mass (phlegmon in Crohn) | May have perianal disease in Crohn; bloody mucus on examination |
| Hemorrhoids | Usually well-appearing | Benign abdominal examination | Visible external hemorrhoids; prolapsing internal hemorrhoids; blood on tissue |
| Anal fissure | Well-appearing but reluctant to have examination | Benign | Visible fissure (usually posterior); severe tenderness; increased sphincter tone |
Important Teaching Point
Physical examination may be entirely normal in many causes of lower gastrointestinal bleeding. Diverticular bleeding, angiodysplasia, small polyps, and even some colorectal cancers may present with completely normal abdominal and rectal examinations (except for the presence of blood). A normal physical examination does not exclude significant pathology and should not delay appropriate investigation. Conversely, the presence of hemorrhoids on examination does not confirm them as the bleeding source — proximal pathology must still be excluded, particularly in patients over 40 or those with red flag features.
5. Differential Diagnosis
Systematic approach organized by probability and clinical features
Acute Lower Gastrointestinal Bleeding (Duration: Less than 3 days)
| Probability | Condition | Key Features | Red Flags |
|---|---|---|---|
| COMMON (approximately 70%) | Diverticular bleeding | Sudden, painless, large-volume maroon or bright red blood; older patient; history of diverticulosis | Hemodynamic instability; ongoing massive bleeding |
| Hemorrhoids | Bright red blood on tissue or dripping; associated with straining; intermittent | Rarely causes significant bleeding; if severe, consider other source | |
| Angiodysplasia (arteriovenous malformations) | Recurrent episodes; elderly; chronic kidney disease; aortic stenosis | Chronic anemia; recurrent transfusion requirements | |
| LESS COMMON (approximately 20%) | Ischemic colitis | Sudden abdominal pain followed by bloody diarrhea within 24 hours; elderly with cardiovascular disease | Peritoneal signs suggest transmural necrosis; recent hypotension or surgery |
| Infectious colitis | Bloody diarrhea with fever; recent travel, antibiotics, or sick contacts | High fever; severe dehydration; toxic appearance | |
| Post-polypectomy bleeding | Colonoscopy with polypectomy within past 2 weeks; delayed bleeding (days 5-14 most common) | Large-volume bleeding; patient on anticoagulation | |
| Inflammatory bowel disease flare | Known history; bloody diarrhea with mucus; cramping abdominal pain | Toxic megacolon signs; severe anemia; systemic toxicity | |
| UNCOMMON BUT SERIOUS (approximately 10%) | Colorectal cancer | Change in bowel habits; weight loss; older age; family history; usually chronic but can present acutely | Obstruction; palpable mass; iron deficiency anemia |
| Upper gastrointestinal source with rapid transit | Brisk upper gastrointestinal bleeding presenting as hematochezia (10-15% of cases) | Hemodynamic instability out of proportion to apparent lower gastrointestinal bleeding; melena or coffee-ground emesis | |
| Mesenteric ischemia | Severe abdominal pain out of proportion to examination; atrial fibrillation; cardiovascular disease | Pain out of proportion; rapid deterioration; acidosis |
Chronic Lower Gastrointestinal Bleeding (Duration: Weeks to months, intermittent or occult)
Step-by-Step Approach to Chronic Lower Gastrointestinal Bleeding:
- Step 1: Rule out upper gastrointestinal source — Upper endoscopy if melena, iron deficiency anemia, or upper gastrointestinal symptoms present
- Step 2: Colonoscopy to evaluate the colon — Mandatory for all patients over 40 or with alarm features
- Step 3: Consider small bowel evaluation if colonoscopy negative — Capsule endoscopy, CT enterography, or deep enteroscopy
- Step 4: Evaluate for systemic causes of bleeding if workup negative — Coagulopathy, platelet disorders
| Probability | Condition | Approximate Frequency | Key Distinguishing Features |
|---|---|---|---|
| COMMON | Hemorrhoids | Up to 40% of chronic hematochezia | Bright red blood on wiping; associated with constipation; visible on examination |
| Colorectal polyps | 15-20% | Often asymptomatic; found on screening; larger polyps more likely to bleed | |
| Colorectal cancer | 10-15% | Change in bowel habits; weight loss; iron deficiency anemia; age greater than 50 | |
| Inflammatory bowel disease | 5-10% | Bloody diarrhea; abdominal pain; younger patients; extra-intestinal manifestations | |
| LESS COMMON | Angiodysplasia | 5-10% | Recurrent bleeding; elderly; renal failure; aortic stenosis |
| Radiation proctitis | 5% | History of pelvic radiation; chronic rectal bleeding; telangiectasias on endoscopy | |
| Anal fissure | 5% | Severe pain with defecation; bright red blood; visible fissure | |
| Solitary rectal ulcer syndrome | Less than 5% | Straining at stool; mucus discharge; feeling of incomplete evacuation | |
| UNCOMMON | Small bowel tumors | 1-2% | Obscure bleeding; may have obstruction symptoms; carcinoid, lymphoma, gastrointestinal stromal tumor |
| Meckel diverticulum | Less than 1% (but important in younger patients) | Painless bleeding in patients under 40; contains ectopic gastric mucosa | |
| Rectal varices | Less than 1% | Portal hypertension; cirrhosis; may cause massive bleeding |
Anatomical Approach to Differential Diagnosis
Anorectal Sources
Hemorrhoids (internal and external)
Anal fissure
Rectal cancer
Rectal varices
Solitary rectal ulcer
Radiation proctitis
Proctitis (infectious, inflammatory)
Left Colon Sources
Diverticular bleeding
Colorectal cancer
Polyps
Ischemic colitis (splenic flexure watershed)
Ulcerative colitis
Sigmoid volvulus
Right Colon Sources
Angiodysplasia (cecum most common)
Diverticular bleeding
Colorectal cancer
Cecal ulcer
Crohn disease (ileocecal)
Typhilitis (neutropenic enterocolitis)
Small Bowel Sources
Angiodysplasia
Crohn disease
Small bowel tumors
Meckel diverticulum
NSAID enteropathy
Dieulafoy lesion
Aortoenteric fistula
Drug-Induced Lower Gastrointestinal Bleeding
| Drug or Drug Class | Mechanism | Characteristics | Management Considerations |
|---|---|---|---|
| Nonsteroidal anti-inflammatory drugs | COX inhibition reduces prostaglandin-mediated mucosal protection; direct epithelial injury | Can cause ulceration and bleeding throughout gastrointestinal tract including colon and small bowel; NSAID enteropathy with diaphragm strictures | Discontinue NSAIDs; consider COX-2 selective agents if anti-inflammatory needed; proton pump inhibitors do not protect lower gastrointestinal tract |
| Aspirin | Irreversible COX-1 inhibition; impairs platelet function | Increases bleeding from pre-existing lesions; particularly diverticular and angiodysplasia bleeding | Weigh cardiovascular benefit versus bleeding risk; low-dose aspirin may be continued if bleeding source treated |
| Clopidogrel and other P2Y12 inhibitors | Inhibits ADP-mediated platelet aggregation | Synergistic bleeding risk with aspirin (dual antiplatelet therapy) | Hold if possible (5-7 days for clopidogrel); consult cardiology if recent stent |
| Warfarin | Vitamin K antagonist; inhibits clotting factor synthesis | Does not cause lesions but unmasks bleeding from existing pathology and prolongs hemorrhage | Check INR; reverse with vitamin K, fresh frozen plasma, or prothrombin complex concentrate if severe |
| Direct oral anticoagulants | Direct thrombin (dabigatran) or factor Xa inhibitors (rivaroxaban, apixaban, edoxaban) | Similar to warfarin — unmasks and prolongs bleeding; shorter half-life than warfarin | Reversal agents: idarucizumab for dabigatran; andexanet alfa for factor Xa inhibitors; prothrombin complex concentrate |
| Selective serotonin reuptake inhibitors | Inhibit platelet serotonin uptake, impairing aggregation | Increased bleeding risk especially when combined with NSAIDs or antiplatelet agents | Consider discontinuation if recurrent bleeding; risk-benefit discussion with psychiatry |
| Antibiotics (Clostridioides difficile) | Disruption of normal flora allows C. difficile overgrowth and toxin production | Watery diarrhea that may become bloody; recent antibiotic use; healthcare exposure | Test for C. difficile toxin; treat with oral vancomycin or fidaxomicin |
| Chemotherapy agents | Direct mucosal toxicity; mucositis; neutropenic enterocolitis | Bloody diarrhea in setting of recent chemotherapy; may be severe if neutropenic | Supportive care; broad-spectrum antibiotics if neutropenic; surgical consultation for typhilitis |
| Kayexalate (sodium polystyrene sulfonate) | Mucosal injury, ischemia; often given with sorbitol | Colonic necrosis, particularly in postoperative or critically ill patients | Avoid in patients with ileus or bowel pathology; alternative potassium binders available |
Differential Diagnosis in Special Populations
| Population | Key Considerations | Unique Etiologies to Consider |
|---|---|---|
| Young adults (18-40 years) | Malignancy less common but not impossible; consider hereditary syndromes | Inflammatory bowel disease, infectious colitis, Meckel diverticulum, hemorrhoids, hereditary polyposis syndromes |
| Immunocompromised patients | Atypical infections; medication-related; graft-versus-host disease | Cytomegalovirus colitis, Kaposi sarcoma, lymphoma, neutropenic enterocolitis, mycobacterial infection |
| Patients with chronic kidney disease | Increased angiodysplasia; platelet dysfunction; anticoagulation for dialysis | Angiodysplasia (particularly cecal), uremic platelet dysfunction, dialysis-associated amyloidosis |
| Patients with cirrhosis | Coagulopathy; portal hypertension; varices | Rectal varices, portal hypertensive colopathy, hemorrhoids, coagulopathy exacerbating other lesions |
| Post-aortic surgery patients | Aortoenteric fistula is rare but catastrophic | Aortoenteric fistula (usually to duodenum but can involve colon), ischemic colitis from hypoperfusion |
| Patients on anticoagulation | Unmasking of underlying lesions; prolonged bleeding | Any lesion may bleed; diverticular and angiodysplasia bleeding more common; need reversal strategy |
Quick Reference: “If You See This, Think This”
| Clinical Clue | Think This First | Next Step |
|---|---|---|
| Painless, large-volume bleeding in elderly patient | Diverticular bleeding | Resuscitate; colonoscopy when prepared and stable |
| Bright red blood on toilet paper only | Hemorrhoids or anal fissure | Anorectal examination; colonoscopy if age greater than 40 or alarm features |
| Abdominal pain followed by bloody diarrhea | Ischemic colitis | CT abdomen; colonoscopy (limited) to confirm; supportive care |
| Bloody diarrhea with fever and recent antibiotics | Clostridioides difficile colitis | Stool C. difficile toxin testing; start empiric treatment |
| Chronic bleeding with iron deficiency anemia | Colorectal cancer until proven otherwise | Colonoscopy; if negative, upper endoscopy and consider small bowel evaluation |
| Recurrent bleeding in patient with aortic stenosis | Angiodysplasia (Heyde syndrome) | Colonoscopy; consider valve replacement if bleeding refractory |
| Bloody diarrhea in young patient with cramping | Inflammatory bowel disease | Stool studies to exclude infection; colonoscopy with biopsies |
| Bleeding 1-2 weeks after colonoscopy with polypectomy | Post-polypectomy bleeding | Repeat colonoscopy for hemostasis (clips, injection) |
| Hematochezia with hemodynamic instability | Consider upper gastrointestinal source (10-15%) | Nasogastric lavage or upper endoscopy first; then colonoscopy |
| History of pelvic radiation with chronic rectal bleeding | Radiation proctitis | Flexible sigmoidoscopy; argon plasma coagulation treatment |
| Bleeding in patient with prior aortic graft | Aortoenteric fistula (until proven otherwise) | CT angiography urgently; surgical consultation |
6. Diagnostic Investigations
A stepwise, cost-effective approach guided by clinical suspicion
Baseline Investigations for All Patients
| Investigation | Purpose | What to Look For | Practical Points |
|---|---|---|---|
| Complete blood count | Assess hemoglobin level and degree of blood loss; platelet count | Hemoglobin and hematocrit (may be normal early in acute bleeding); microcytic anemia suggests chronic loss; thrombocytopenia | Serial measurements every 4-8 hours in acute bleeding; hemoglobin may take 24-72 hours to equilibrate after acute hemorrhage |
| Basic metabolic panel | Assess renal function, electrolytes | Elevated BUN:creatinine ratio (greater than 30:1) suggests upper gastrointestinal source; assess renal function before contrast | Blood in gastrointestinal tract is absorbed as protein, elevating BUN |
| Coagulation studies (PT/INR, PTT) | Detect coagulopathy; guide reversal | Elevated INR in warfarin use or liver disease; prolonged PTT in heparin use or factor deficiencies | Essential before invasive procedures; determine if reversal needed |
| Type and screen (or crossmatch) | Prepare for transfusion | Blood type and antibody screen | Crossmatch 2-4 units for significant bleeding; activate massive transfusion protocol if severe |
| Liver function tests | Detect liver disease affecting coagulation | Elevated bilirubin, low albumin, elevated INR suggest cirrhosis with synthetic dysfunction | Portal hypertension may cause rectal varices |
| Lactate | Assess tissue perfusion in significant bleeding | Elevated lactate (greater than 2 mmol/L) suggests inadequate perfusion | Useful marker of shock severity; trend with resuscitation |
| Electrocardiogram | Detect cardiac ischemia from anemia; assess rhythm | ST changes suggesting demand ischemia; atrial fibrillation (often on anticoagulation) | Particularly important in elderly and those with cardiovascular disease |
Risk Stratification Tools
Oakland Score for Lower Gastrointestinal Bleeding
The Oakland score helps identify patients with lower gastrointestinal bleeding who can be safely managed as outpatients. Score components include:
- Age, sex, prior lower gastrointestinal bleeding admission
- Digital rectal examination findings (no blood, blood, melena)
- Heart rate, systolic blood pressure
- Hemoglobin level
Score interpretation: Oakland score ≤8 indicates greater than 95% probability of safe discharge (low risk of rebleeding, transfusion, intervention, or death within 28 days).
Colonoscopy: The Primary Diagnostic and Therapeutic Tool
| Aspect | Details | Clinical Significance |
|---|---|---|
| Timing | Within 24 hours for most acute lower gastrointestinal bleeding after hemodynamic stabilization and bowel preparation | Early colonoscopy (less than 24 hours) increases diagnostic yield but has not consistently shown mortality benefit; urgent if high-risk features |
| Bowel preparation | 4-6 liters of polyethylene glycol solution over 3-4 hours; may use nasogastric tube if needed | Adequate preparation essential for visualization; unprepared colonoscopy has low diagnostic yield |
| Diagnostic yield | Identifies bleeding source in 45-90% of cases depending on timing and preparation quality | Higher yield with early colonoscopy and good preparation; stigmata of recent hemorrhage found in 20-25% |
| Therapeutic capability | Hemostasis achieved with clips, thermal coagulation, injection therapy, band ligation | Endoscopic therapy reduces rebleeding and need for surgery in patients with stigmata of recent hemorrhage |
| Stigmata of recent hemorrhage | Active bleeding, visible vessel, adherent clot, pigmented spot in diverticulum or other lesion | Presence indicates high-risk lesion requiring endoscopic treatment |
When to Consider Upper Endoscopy First
Rule of 10-15%: Approximately 10-15% of patients presenting with hematochezia have an upper gastrointestinal source. Consider upper endoscopy before or instead of colonoscopy in the following situations:
- Hemodynamic instability with hematochezia — brisk upper gastrointestinal bleeding can present this way
- Blood or coffee-ground material on nasogastric aspirate
- Elevated BUN:creatinine ratio (greater than 30:1)
- History of upper gastrointestinal disease (peptic ulcer, varices)
- Melena with or without hematochezia
- Symptoms of upper gastrointestinal pathology (epigastric pain, nausea, vomiting)
CT Angiography
| Indication | Technique | Advantages | Limitations |
|---|---|---|---|
| Active, severe bleeding when colonoscopy not feasible or has failed to identify source; hemodynamically unstable patient | Multiphasic CT with arterial and delayed phases; no bowel preparation required | Rapid; available 24/7; can detect bleeding rates as low as 0.3-0.5 mL/minute; localizes source for angiographic or surgical intervention | Requires active bleeding at time of scan; radiation exposure; IV contrast required; does not allow therapeutic intervention |
Positive CT Angiography Finding
Active extravasation: Contrast blush within bowel lumen on arterial phase that increases on delayed phase. Indicates active bleeding at greater than 0.3-0.5 mL/minute.
Next step: Proceed to conventional angiography for embolization or surgical consultation.
Negative CT Angiography
Interpretation: No active extravasation; bleeding rate may be less than detectable threshold or bleeding has stopped.
Next step: Stabilize and proceed with colonoscopy; consider repeat CT angiography or nuclear medicine scan if rebleeding.
Conventional Angiography with Embolization
| Indication | Technique | Success Rate | Complications |
|---|---|---|---|
| Active bleeding identified on CT angiography; massive bleeding when colonoscopy not feasible; failed endoscopic hemostasis | Selective catheterization of mesenteric vessels; super-selective embolization with coils or particles | Technical success 80-90%; clinical success (bleeding cessation) 70-80% | Bowel ischemia (less than 5% with super-selective technique); rebleeding (15-25%); access site complications |
Nuclear Medicine Bleeding Scan (Tagged Red Blood Cell Scan)
Indications
- Intermittent bleeding with negative colonoscopy and CT angiography
- Slow bleeding (as low as 0.1 mL/minute detectable)
- Localization before surgery or angiography
Limitations
- Poor anatomical resolution — localizes to region, not exact site
- Time-consuming (may take hours)
- Activity may be detected from prior bleeding, not current
- Does not allow therapeutic intervention
Small Bowel Evaluation (For Obscure Bleeding)
When to Evaluate the Small Bowel
Consider small bowel evaluation when upper endoscopy and colonoscopy are both negative and bleeding persists or recurs. This is termed “obscure gastrointestinal bleeding” and the small bowel is the source in 5-10% of all gastrointestinal bleeding cases.
| Modality | Technique | Diagnostic Yield | When to Use |
|---|---|---|---|
| Video capsule endoscopy | Swallowed camera capsule transmits images throughout transit | 60-70% for obscure gastrointestinal bleeding; higher yield when performed during or close to bleeding episode | First-line for stable patients with obscure gastrointestinal bleeding after negative bidirectional endoscopy |
| Deep enteroscopy (balloon-assisted) | Single or double balloon enteroscopy allows intubation of deep small bowel | Similar to capsule endoscopy but allows biopsy and therapeutic intervention | After positive capsule endoscopy to treat identified lesion; when therapy anticipated |
| CT enterography | CT with oral contrast optimized for small bowel imaging | Best for masses, strictures, Crohn disease; less sensitive for vascular lesions | When mass lesion or Crohn disease suspected; complements capsule endoscopy |
| Meckel scan (technetium-99m pertechnetate) | Nuclear medicine scan detecting ectopic gastric mucosa | 85% sensitivity in children; lower in adults | Young patients (less than 40 years) with obscure gastrointestinal bleeding; painless bleeding |
Targeted Investigations by Suspected Etiology
If Suspecting Inflammatory Bowel Disease
Initial Tests
- Fecal calprotectin: Elevated in intestinal inflammation (greater than 50-200 μg/g suggests active inflammation); helps differentiate from irritable bowel syndrome
- C-reactive protein: Elevated in active inflammation; correlates with disease activity
- Stool studies: Exclude infectious etiologies before diagnosing inflammatory bowel disease
Definitive Tests
- Colonoscopy with biopsies: Gold standard; assess extent, severity, histologic features
- CT or MR enterography: Evaluate small bowel involvement, strictures, fistulas in Crohn disease
- Upper endoscopy: Assess for upper gastrointestinal Crohn disease
If Suspecting Infectious Colitis
Stool Studies
- Stool culture: Salmonella, Shigella, Campylobacter, E. coli O157:H7
- Clostridioides difficile testing: PCR or toxin immunoassay; in patients with recent antibiotic use or healthcare exposure
- Ova and parasites: If travel history or exposure risk (Entamoeba histolytica)
Additional Tests
- Stool PCR panels: Multiplex testing for bacterial, viral, and parasitic pathogens
- Cytomegalovirus testing: In immunocompromised patients (serology, tissue PCR, immunohistochemistry on biopsy)
If Suspecting Ischemic Colitis
Initial Tests
- CT abdomen and pelvis with IV contrast: Bowel wall thickening, thumbprinting, pericolonic stranding; assess for pneumatosis or portal venous gas (concerning for severe ischemia)
- Lactate: May be elevated but not specific; normal lactate does not exclude ischemia
Confirmatory Tests
- Colonoscopy (limited, cautious): Edematous, friable mucosa; hemorrhagic or cyanotic patches; ulceration in severe cases; biopsies show characteristic changes
- CT angiography: If mesenteric arterial occlusion suspected (severe cases)
Empiric Treatment Trials as Diagnostic Tools
When Diagnosis Remains Unclear
In select cases of recurrent lower gastrointestinal bleeding with negative comprehensive workup, empiric treatment trials may help identify the etiology:
- Discontinue antiplatelet and NSAID therapy: If feasible, stop aspirin, NSAIDs, and clopidogrel for 4-6 weeks and monitor for resolution — suggests drug-related bleeding
- Iron supplementation trial: In patients with iron deficiency anemia and negative workup, replenish iron and monitor for recurrence — if iron deficiency recurs, suggests ongoing occult blood loss
- Hormonal therapy for angiodysplasia: Historically tried but not currently recommended due to lack of efficacy
- Octreotide for refractory angiodysplasia bleeding: May reduce transfusion requirements in select cases
Investigation Algorithm Summary
Stepwise Approach:
- All patients: Complete blood count, metabolic panel, coagulation studies, type and screen
- Hemodynamically unstable or severe bleeding: Consider CT angiography → conventional angiography with embolization if positive
- Hemodynamically stable: Bowel preparation → colonoscopy within 24 hours
- Concern for upper gastrointestinal source: Upper endoscopy first or nasogastric lavage
- Colonoscopy negative: Consider upper endoscopy if not done; then capsule endoscopy for small bowel evaluation
- All modalities negative with recurrent bleeding: Repeat evaluation during active bleeding episode; consider intraoperative enteroscopy; surgical exploration in life-threatening cases
7. Pattern Recognition and Clinical Decision-Making
Practical algorithms and decision pathways
Step 1: Is This Urgent?
| Clinical Scenario | Urgency Level | Immediate Action |
|---|---|---|
| Hemodynamic instability (systolic blood pressure less than 90 mmHg, heart rate greater than 100, altered mental status) | EMERGENT | Two large-bore IV lines; aggressive fluid resuscitation; type and crossmatch; activate massive transfusion protocol if needed; ICU admission; consider CT angiography if too unstable for colonoscopy |
| Ongoing large-volume bleeding with clots; dropping hemoglobin despite transfusion | EMERGENT | Transfuse to hemoglobin greater than 7-8 g/dL; CT angiography for localization; interventional radiology or surgical consultation; urgent colonoscopy if stabilizes |
| Patient on anticoagulation with significant bleeding | EMERGENT | Assess need for reversal; administer reversal agents as indicated; hold anticoagulation; consult cardiology regarding anticoagulation management |
| Severe abdominal pain with bloody diarrhea (concern for ischemia) | EMERGENT | CT abdomen with IV contrast; surgical consultation; broad-spectrum antibiotics if perforation suspected; lactate and serial abdominal examinations |
| Moderate bleeding with stable vital signs; hemoglobin greater than 9 g/dL | URGENT | Admit to monitored bed; bowel preparation; colonoscopy within 24 hours; serial hemoglobin monitoring |
| Intermittent small-volume bright red blood per rectum; hemodynamically stable | URGENT | Anorectal examination; if hemorrhoids visible and low-risk features, can consider outpatient colonoscopy; admit if elderly or alarm features |
| Occult blood positive or iron deficiency anemia; no overt bleeding | ROUTINE | Outpatient colonoscopy scheduled within 2-4 weeks; iron supplementation; complete bidirectional endoscopy evaluation |
| Known hemorrhoids with typical minor bleeding; age less than 40, no alarm features | ROUTINE | Conservative management; dietary modification; consider outpatient evaluation if persistent |
Step 2: Initial Resuscitation and Stabilization
Resuscitation Priorities:
- Airway and breathing: Protect airway if altered mental status or massive hematemesis; supplemental oxygen
- Circulation: Two large-bore (18-gauge or larger) peripheral IVs; begin crystalloid resuscitation
- Transfusion: Target hemoglobin greater than 7-8 g/dL in most patients; higher threshold (greater than 9 g/dL) if active coronary artery disease
- Coagulopathy correction: Reverse anticoagulation if life-threatening bleeding; fresh frozen plasma, vitamin K, or specific reversal agents as indicated
- Monitoring: Continuous telemetry; Foley catheter for urine output; serial hemoglobin every 4-8 hours
| Transfusion Trigger | Target | Rationale |
|---|---|---|
| Hemoglobin less than 7 g/dL | Transfuse to hemoglobin 7-9 g/dL | Restrictive transfusion strategy associated with better outcomes in gastrointestinal bleeding |
| Active coronary artery disease or ongoing ischemia | Transfuse to hemoglobin greater than 8-9 g/dL | Higher oxygen-carrying capacity needed; prevent demand ischemia |
| Massive hemorrhage with shock | Activate massive transfusion protocol (1:1:1 ratio of packed red blood cells, fresh frozen plasma, platelets) | Prevent dilutional coagulopathy; balanced resuscitation |
Step 3: Classify Severity and Determine Disposition
Low Risk (Outpatient Management Possible)
Criteria:
- Oakland score ≤8
- Hemodynamically stable
- No significant comorbidities
- Hemoglobin greater than 10 g/dL
- No ongoing bleeding
- Reliable follow-up available
Action: Outpatient colonoscopy within 7 days
Moderate Risk (Admission Required)
Criteria:
- Stable vital signs but ongoing bleeding
- Hemoglobin 7-10 g/dL
- Significant comorbidities
- Anticoagulant use
- Age greater than 60
Action: Admit to ward; colonoscopy within 24 hours
High Risk (ICU Admission)
Criteria:
- Hemodynamic instability
- Transfusion requirement greater than 2 units
- Active ongoing bleeding
- Hemoglobin less than 7 g/dL
- Coagulopathy requiring reversal
Action: ICU; CT angiography if unstable; urgent colonoscopy when stabilized
Step 4: Follow the Appropriate Algorithm
Algorithm A: Acute Severe Lower Gastrointestinal Bleeding
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Hemodynamically unstable despite resuscitation | Massive arterial bleeding (diverticular, post-polypectomy, Dieulafoy) | CT angiography → angiographic embolization if positive; surgical consultation |
| Stabilizes with resuscitation; ongoing moderate bleeding | Diverticular bleeding, angiodysplasia | Rapid bowel preparation → colonoscopy within 12-24 hours |
| Hematochezia with elevated BUN:creatinine or hematemesis | Upper gastrointestinal source (10-15% of hematochezia cases) | Upper endoscopy first; then colonoscopy if negative |
| Bleeding stops spontaneously; patient stabilizes | Self-limited diverticular or angiodysplastic bleeding | Bowel preparation; colonoscopy within 24 hours to identify source |
Algorithm B: Moderate Lower Gastrointestinal Bleeding (Stable Patient)
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Painless maroon or bright red blood; elderly patient | Diverticular bleeding | Admit; bowel preparation; colonoscopy within 24 hours |
| Abdominal pain followed by bloody diarrhea; elderly with vascular disease | Ischemic colitis | CT abdomen; limited colonoscopy to confirm; supportive care; surgery if signs of necrosis |
| Bloody diarrhea with fever; recent antibiotics | Clostridioides difficile colitis | Stool C. difficile testing; start empiric oral vancomycin; supportive care |
| Bloody diarrhea; young patient with cramping | Inflammatory bowel disease or infectious colitis | Stool studies; colonoscopy with biopsies; start treatment based on findings |
| Bleeding 5-14 days after colonoscopy with polypectomy | Post-polypectomy bleeding | Repeat colonoscopy; endoscopic hemostasis (clips, injection) |
Algorithm C: Minor or Chronic Lower Gastrointestinal Bleeding
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Bright red blood on toilet paper; straining; no alarm features; age less than 40 | Hemorrhoids | Anorectal examination; conservative management; colonoscopy if persistent or alarm features develop |
| Severe pain with defecation; bright red blood; visible fissure | Anal fissure | Conservative management (fiber, sitz baths, topical therapy); colonoscopy if atypical location or refractory |
| Iron deficiency anemia; positive fecal occult blood; age greater than 45 | Colorectal neoplasia until proven otherwise | Colonoscopy; if negative, upper endoscopy; then small bowel evaluation if anemia persists |
| Recurrent intermittent bleeding; elderly with renal disease or aortic stenosis | Angiodysplasia | Colonoscopy; treat with argon plasma coagulation if found; may require repeated treatments |
| Chronic rectal bleeding; history of pelvic radiation | Radiation proctitis | Flexible sigmoidoscopy; argon plasma coagulation; topical therapies |
Managing Anticoagulation in Lower Gastrointestinal Bleeding
| Agent | Action in Severe Bleeding | Reversal Strategy | Restarting Anticoagulation |
|---|---|---|---|
| Warfarin | Hold; check INR | Vitamin K 10 mg IV; 4-factor prothrombin complex concentrate for life-threatening bleeding; fresh frozen plasma if prothrombin complex concentrate unavailable | Resume when hemostasis achieved and bleeding source treated; typically 7 days; individualize based on thrombotic risk |
| Dabigatran | Hold; assess renal function | Idarucizumab 5 g IV for life-threatening bleeding; hemodialysis removes drug | Resume based on renal clearance; typically 48-72 hours after hemostasis |
| Rivaroxaban, Apixaban, Edoxaban | Hold; renal clearance varies | Andexanet alfa if available; 4-factor prothrombin complex concentrate as alternative | Resume typically 48-72 hours after hemostasis; sooner if high thrombotic risk |
| Heparin (unfractionated) | Stop infusion; short half-life (1-2 hours) | Protamine sulfate if immediate reversal needed | Resume when bleeding controlled; bridge to oral anticoagulation |
| Low-molecular-weight heparin | Hold doses | Protamine provides partial reversal | Resume 24-48 hours after hemostasis |
| Aspirin | Hold if possible; consider continuing if recent coronary stent | Platelet transfusion if life-threatening bleeding (effect lasts 7-10 days) | Resume once bleeding source identified and treated; often within 3-5 days |
| Clopidogrel | Hold; consult cardiology if recent stent | Platelet transfusion if life-threatening bleeding | Resume based on indication; typically 5-7 days after hemostasis if high thrombotic risk |
“What Do I Do If…” Decision Reference
| Clinical Situation | Immediate Action | Next Step |
|---|---|---|
| Colonoscopy shows diverticula but no active bleeding or stigmata | Presume diverticular source if no other lesion found | Conservative management; repeat colonoscopy or CT angiography if rebleeding |
| Active bleeding seen at colonoscopy | Attempt endoscopic hemostasis (injection, clips, thermal coagulation) | If successful, observe; if unsuccessful, interventional radiology or surgery |
| Colonoscopy negative but patient continues bleeding | Upper endoscopy if not already done | CT angiography during active bleeding; nuclear medicine scan if intermittent; capsule endoscopy if stable |
| CT angiography shows active extravasation | Proceed directly to conventional angiography | Super-selective embolization of bleeding vessel; surgical backup |
| Embolization performed but patient rebleeds | Repeat angiography if hemodynamically stable | Surgical resection if repeat embolization fails or not feasible |
| Patient has known hemorrhoids — is colonoscopy needed? | Yes, if age greater than 40, family history of colorectal cancer, or any alarm features | Colonoscopy to exclude proximal pathology; treat hemorrhoids if confirmed as source |
| Ischemic colitis diagnosed on colonoscopy | Supportive care; IV fluids; bowel rest | Serial abdominal examinations; surgical consultation if peritoneal signs or lack of improvement |
| Inflammatory bowel disease flare with bleeding | Confirm diagnosis; exclude superimposed infection (C. difficile, cytomegalovirus) | Escalate inflammatory bowel disease therapy (steroids, biologics); transfuse as needed; surgical consultation if toxic megacolon |
| Recurrent bleeding despite negative comprehensive workup | Repeat evaluation during active bleeding episode | Consider intraoperative enteroscopy; empiric segmental resection as last resort with surgical localization |
Troubleshooting Refractory Lower Gastrointestinal Bleeding
Ask These Questions
- Was the bowel preparation adequate for colonoscopy? Poor preparation significantly reduces diagnostic yield.
- Was upper endoscopy performed to exclude upper gastrointestinal source? Remember: 10-15% of hematochezia originates above the ligament of Treitz.
- Was the patient actively bleeding at the time of investigation? Intermittent bleeding may be missed.
- Were all medications reviewed? NSAIDs and anticoagulants may cause or exacerbate bleeding.
- Was the small bowel evaluated? Capsule endoscopy or enteroscopy indicated after negative bidirectional endoscopy.
- Could there be multiple bleeding sources? Elderly patients may have both diverticula and angiodysplasia.
- Is there an underlying coagulopathy that needs correction?
- Was the correct diagnosis made? Reevaluate the clinical picture and consider alternative diagnoses.
8. Clinical Pearls and Pitfalls
Practical wisdom — learn from successes and avoid common mistakes
Must-Know Clinical Pearls
The 10-15% Rule: Approximately 10-15% of patients presenting with hematochezia have an upper gastrointestinal source. Always consider upper endoscopy first in hemodynamically unstable patients or those with elevated BUN:creatinine ratio.
Self-Limited Bleeding: Lower gastrointestinal bleeding stops spontaneously in 80-85% of cases. However, recurrence rates are significant — up to 25-40% for diverticular bleeding and 50% for angiodysplasia.
Diverticular Bleeding is Painless: Diverticular hemorrhage occurs from arterial rupture over the diverticular dome and is typically sudden, painless, and self-limited. If the patient has significant abdominal pain with bleeding, consider diverticulitis, ischemic colitis, or another diagnosis.
Heyde Syndrome: The triad of aortic stenosis, acquired von Willebrand syndrome, and gastrointestinal angiodysplasia. Consider this in elderly patients with recurrent gastrointestinal bleeding and a heart murmur. Valve replacement may be curative.
Arnold’s Nerve Connection: Stimulation of the external auditory canal (Arnold’s nerve, a branch of the vagus) can trigger cough and, in some patients, may influence gastrointestinal symptoms. Always perform a complete examination including the ears.
Hemorrhoids Don’t Exclude Proximal Disease: Finding hemorrhoids on examination does not confirm them as the bleeding source. Patients over 40 or those with alarm features require colonoscopy regardless of hemorrhoid presence.
Right-Sided Diverticula Bleed More: Although diverticula are more common in the left colon, bleeding more frequently originates from right-sided diverticula due to their larger size and thinner walls.
Restrictive Transfusion Strategy: Target hemoglobin of 7-8 g/dL in most patients with gastrointestinal bleeding. Liberal transfusion (targeting greater than 9 g/dL) is associated with worse outcomes except in patients with active coronary artery disease.
Critical Pitfalls to Avoid
Assuming Hematochezia Means Lower Source: Never assume bright red blood per rectum excludes an upper gastrointestinal source. Brisk upper gastrointestinal bleeding with rapid transit can present as hematochezia. Always consider upper endoscopy in unstable patients.
Attributing Bleeding to Hemorrhoids Without Workup: The most dangerous pitfall is attributing rectal bleeding to hemorrhoids without age-appropriate evaluation. Colorectal cancer can coexist with hemorrhoids and may be missed if colonoscopy is not performed.
Relying on Normal Hemoglobin in Acute Bleeding: Hemoglobin takes 24-72 hours to equilibrate after acute hemorrhage. A normal hemoglobin in the emergency department does not exclude significant blood loss. Trend serial values and assess clinically.
Performing Unprepared Colonoscopy: Colonoscopy without adequate bowel preparation has a dramatically reduced diagnostic yield (less than 30%). Take time to properly prepare the patient unless emergent surgery is indicated.
Forgetting About Medications: Always review the medication list. NSAIDs cause lower gastrointestinal bleeding and enteropathy. Anticoagulants unmask bleeding from underlying lesions. Stopping the culprit medication is part of treatment.
Missing Aortoenteric Fistula: In any patient with a history of aortic surgery (especially aortic graft) presenting with gastrointestinal bleeding, aortoenteric fistula must be considered until proven otherwise. This is rare but rapidly fatal if missed.
Ignoring Ischemia Warning Signs: Abdominal pain followed by bloody diarrhea is ischemic colitis until proven otherwise. Pain out of proportion to examination suggests mesenteric ischemia — a surgical emergency. Do not delay imaging.
Over-Transfusing: Liberal transfusion strategies increase rebleeding rates and mortality in gastrointestinal bleeding. Transfuse to a target of 7-8 g/dL unless the patient has active cardiac ischemia.
Key Takeaways
- Lower gastrointestinal bleeding accounts for 20-25% of gastrointestinal hemorrhage; mortality is 2-4% overall but higher in hospitalized patients and the elderly.
- The “Big Five” causes are diverticulosis, angiodysplasia, colorectal neoplasia, colitis (ischemic, infectious, inflammatory), and anorectal disease (hemorrhoids, fissures).
- Diverticular bleeding is the most common cause of acute lower gastrointestinal bleeding — typically painless, sudden, and self-limited, but with significant recurrence rates.
- Always consider upper gastrointestinal source in patients with hematochezia, especially if hemodynamically unstable (10-15% rule).
- Use the “BLEED” mnemonic for comprehensive history: Blood characteristics, Location clues, Episodes and duration, Extra symptoms, Drugs and diseases.
- The digital rectal examination is mandatory — it confirms bleeding, assesses stool color, and may identify anorectal pathology.
- Colonoscopy within 24 hours is the primary diagnostic and therapeutic modality for stable patients after adequate bowel preparation.
- CT angiography is the preferred initial test for hemodynamically unstable patients — it localizes bleeding for angiographic embolization or surgical planning.
- Risk stratification with the Oakland score helps identify low-risk patients who may be safely managed as outpatients.
- Anticoagulation should be held in significant bleeding; reversal agents are available and should be used for life-threatening hemorrhage with appropriate multidisciplinary input.
- If colonoscopy is negative and bleeding persists, pursue upper endoscopy (if not done), then small bowel evaluation with capsule endoscopy.
- Finding hemorrhoids does not exclude proximal pathology — colonoscopy is indicated for patients over 40 or those with alarm features regardless of hemorrhoid presence.
Quick Reference Algorithm
Systematic Approach to Lower Gastrointestinal Bleeding:
- Assess hemodynamic stability: If unstable, resuscitate with IV fluids and blood products; consider ICU admission.
- Obtain baseline labs: Complete blood count, metabolic panel, coagulation studies, type and crossmatch.
- Rule out upper gastrointestinal source: Consider upper endoscopy first if hemodynamically unstable, elevated BUN:creatinine, or melena present.
- Correct coagulopathy: Hold anticoagulants; reverse if life-threatening bleeding; consult relevant specialists.
- Stratify risk: Use Oakland score or clinical judgment to determine disposition (outpatient vs. admission vs. ICU).
- Prepare and perform colonoscopy: Bowel preparation is essential; colonoscopy within 24 hours for most acute presentations.
- If colonoscopy negative and bleeding continues: CT angiography if active; capsule endoscopy if stable; nuclear medicine scan if intermittent.
- Treat underlying cause: Endoscopic therapy, embolization, surgery, or medical management based on etiology.
- Plan follow-up: Surveillance colonoscopy; medication review; resume anticoagulation when safe based on thrombotic risk.